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TECHNICAL NOTE
Exposure to excessive fluoride during hemodialysis
WILLIAM J. JOHNSON and DONALD R. TAVES
Division of Nephrology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, and the Department
of Pharmacology and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, New York
The safety of fluoridated community water supplies
for dialysate and long-term intermittent hemodialysis
has been questioned since 1965 [1]. The only signifi-
cant means of clearing fluoride from body fluids are
renal excretion and incorporation into bone [2]. When
dialysate is prepared with fluoridated water, fluoride
ion moves along a concentration gradient from
dialysate to blood [3, 4]. Because renal excretion is
defective or absent in such patients, the fluoride
administered during dialysis is incorporated into the
skeleton. Under these conditions, serum fluoride con-
centrations increase progressively, and the bone con-
tent of fluoride rises above values obtained in persons
with normal renal function who drink water that is
fluoridated [3—6] (the serum fluoride concentration in
normal persons who drink water with a fluoride con-
centration of 53 LM [1 ppm] is 0.7 0.4 LM [mean
SD]). Although it has not been established that fluori-
dated dialysate adversely affects the bone of patients
maintained by hemodialysis, this possibility exists,
particularly in patients who have been exposed to
such a dialysate for many years. This and other
problems associated with various substances in tap
water have made deionization of water used for dialy-
sate a common practice. Unfortunately, if the de-
ionizer is improperly maintained, the fluoride content
of the water may actually increase as the deionizer
becomes exhausted.
Methods and Results. To determine whether the
excessive use of a deionizer could result in elution of
retained fluoride, polystyrene tubing (224 mm long,
8 mm I.D.) was filled with resin taken from an ion
exchanger (Illgo-Way) supplied by the illinois Water
Treatment Company, Rochester, Illinois. Tap water
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with a fluoride concentration of 41 .M was made to
flow by gravity through the resin. The cumulative
volume of effluent was measured; the concentration of
fluoride was measured by the modified diffusion
technique; and fluorescence was determined with the
Morin-Thorin reagent [7, 8].
Fluoride was eluted when the deionizer column was
exhausted, after which the concentration of fluoride in
the effluent became the same as in tap water (Fig. 1).
To determine the point at which elution of fluoride
occurred with a commercial deionizer (Culligan) used
for dialysis patients, fluoridated tap water was allowed
to run through the deionizer until it became exhausted.
Electric resistance of the effluent and the total dis-
solved solids, osmolality, pH and concentrations of
calcium, magnesium and fluoride were measured at
regular intervals. Results indicate that the concentra-
tion of fluoride increased abruptly when the resistance
of the effluent was less than 80,000 ohms (Table 1).
The concentrations of calcium and magnesium, how-
ever, did not exceed the concentrations of these sub-
stances in the tap water at any point. The peak con-
centration of fluoride in the effluent was approximately
three times higher than that in the untreated tap water.
The practical consequence of this observation was
possibly observed in the following patient: A 46-year-
old man with bilateral polycystic renal disease was
maintained by long-term intermittent hemodialysis. At
first, a commercial water softener (Culligan), which
provided fluoridated water, was used (1 ppm, 53 ELM).
The mean calcium concentration of the dialysate was
7.2 mg/100 ml, and the mean magnesium concentra-
tion was 1.6 mg/100 ml. Results of serial determina-
tions of serum and dialysate concentrations of fluoride,
calcium and magnesium; serum concentrations of
phosphorus and alkaline phosphatase activity; and
radioimmunoassays of parathyroid hormone con-
centrations are shown in Fig. 2.
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Fig. 1. Fluoride concentration in tile effluent from an ion-
exchanger related to the volume of Water which was passed
through it.
Although the initial skeletal survey showed no
evidence of bone disease, within a year after starting
dialysis the patient complained of chest pain and pain
in the feet, and the skeletal radiologic survey showed
generalized demineralization and fractures of the fifth
through the eighth ribs posteriorly, but no evidence of
bone resorption. In spite of a good appetite and a good
intake of food, his body weight decreased by 11 kg.
Fig. 2. Serum and dialysate fluoride, calcium and magnesium
concentrations and serum phosphorus, serum alkaline phos-
phatase activity, and radioimmunoassay values for serum para-
thyroid hormone in a patient exposed to fluoridated dialysate who
subsequently received a renal allograft.
Because we had not seen such severe bone disease in
a patient while on relatively high concentrations of
dialysate calcium when fluoride-free dialysate had
been employed, we recommended in October, 1968,
that a commercial mixed-bed (Culligan) deionizer be
installed to remove the fluoride. Repeated deter-
minations of fluoride in the dialysate, however, showed
Table 1. Composition of effluent from deionizer
Resistance,
ohms
Total dissolved
solids, ppm
mOsm/kg pH Calcium,
mg/100 ml
Magnesium,
mgj 100 ml
Fluoride,
sM
1,000,000
200,000
100,000
80,000
40,000
20,000
10,000
5,000
0
0.75
2.00
8.00
10.00
25.00
38.00
100.00
210.00
310.00
0
0
1.0
1.0
4.0
—
7.5
10.0
12.0
7.6
8.0
6.1
6.1
5.2
5.4
6.1
6.7
7.1
0.01
0.02
0.03
0.04
0.08
0.12
0.20
0.62
1.56
0
0.01
0.04
0.05
0.14
0.21
0.37
0.77
2.22
0.1
1.2
5.4
7.9
22.9
112.3
230.0
152.0
113.5
Tap water
Start
End
290.00
310.00
12.0
12.0
6.4
6.8
7.65
7.40
2.10
2.08
68.0
73.2
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variable concentrations, the levels sometimes exceed-
ing the concentration of fluoride in tap water (Fig. 2).
Inspection of the apparatus indicated that because the
conductivity meter was defective, the patient had been
using the water meter to determine when the deionizer
required regeneration (after approximately 5,000
gallons of water had been used). Although this
practice did not result in dangerous elevations of
calcium or magnesium in the dialysate, fluoride ap-
peared to be eluted from the column when the resin
was exhausted. In April, 1969, a new conductivity
meter was installed, and the resin was regenerated
when the conductivity of the water indicated a resis-
tance of 80,000 ohms. Consequently, dialysate and
serum fluoride concentrations decreased (Fig. 2).
Bone biopsy specimens of the iliac crest taken in
April and three months later were examined by the
microradiographic technique [9]. They showed severe
osteomalacia, increased bone resorption and de-
creased bone formation. Bone resorption decreased
and osteomalacia improved, coincident with the
lowering of dialysate, serum and bone concentrations
of fluoride. Bone fluoride decreased from 3.38 to 2.97
fluoride/calcium M% (normal, 0.5 to 1.0 M%).
In spite of this, the patient did not improve clinically.
Since it seemed unlikely that sufficient fluoride could
be removed by dialysis alone, it was decided to pro-
ceed with transplantation. During the interval between
the preliminary nephrectomy and splenectomy and
subsequent renal transplantation, he experienced a
grand mal seizure and suffered additional fractures of
the right fifth rib, the fifth lumbar vertebra and the
right femoral neck. In February, 1970, renal trans-
plantation was carried out successfully using a kidney
from a sibling donor. Bone pain gradually subsided.
The patient regained 21 kg of body weight, and serial
roentgenograms showed remineralization of the
skeleton and healing of the fractures.
Immediately after successful renal transplantation,
the patient excreted 319 moles of fluoride in the
urine per day, though there was no fluoride in his
drinking water. After dismissal from the hospital, he
returned to his community where the water was
fluoridated. Two years later in February, 1972, the
serum creatinine concentration was 1.35 mg/l00 ml
and the endogenous creatinine clearance, 84 mI/mini
1.73 m2. The serum fluoride concentration remained
elevated to 2.6 sM, but urinary excretion offluoride had
decreased into the normal range of 62 smoles/day.
Discussion. These data indicate that a patient
maintained by hemodialysis in a community using
fluoridated water may be exposed to a fluoride con-
centration higher than that present in tap water if the
deionizer is allowed to become exhausted while the
patient is being dialyzed. The concentration reached
520 sM in the laboratory deionizer and 230 M in the
patient's model. Since the concentration of fluoride in
blood returning from the dialyzer is about one-half to
two-thirds that in the dialysate, the concentration could
reach 150 SM in human serum. This would probably
not be fatal inasmuch as concentrations of 500 to
1,400 sM are necessary to cause death of the rat or
rabbit [11, 12]. Repeated exposures to excessive fluo-
ride concentrations, however, could lead to saturation
of the skeleton with fluoride and sustained elevation of
serum fluoride to concentrations of more than 30 sM.
Under these circumstances, loss of weight and distur-
bance of bone mineralization or other toxic effects
could occur. The excessive amounts of osteoid seen in
the bone biopsy specimen and the decrease in osteo-
malacia subsequent to correcting the deionizer opera-
tion are consistent with a fluoride effect. However, it is
not necessary to prove that our patient was harmed by
excessive concentrations of fluoride to make the point
that unwarranted risks are taken when fluoride is
allowed to accumulate in the deionizer and to elute
during dialysis, and to suggest that there be a syste-
matic check to guard against the use of a deionizer
beyond its capacity.
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